Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFα
Hadar Edelman-Klapper, Eran Zittan, Ariella Bar‐Gil Shitrit, Keren M. Rabinowitz, Idan Goren, Irit Avni‐Biron, Jacob E. Ollech, Lev Lichtenstein, Hagar Banai-Eran, Henit Yanai, Yifat Snir, Maor H. Pauker, Adi Friedenberg, Adva Levy‐Barda, Arie Segal, Yelena Broitman, Eran Maoz, Baruch Ovadia, Maya Aharoni Golan, Eyal Shachar, Shomron Ben‐Horin, Tsachi-Tsadok Perets, Haim Ben Zvi, Rami Eliakim, Revital Barkan, Sophy Goren, Michal Navon, Noy Krugliak, Michal Werbner, Joel Alter, Moshe Dessau, Meital Gal-Tanamy, Natalia T. Freund, Dani Cohen, Iris Dotan
Topics & Concepts
SerologyCoronavirus disease 2019 (COVID-19)Inflammatory Bowel DiseasesMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Tumor necrosis factor alphaImmunology2019-20 coronavirus outbreakInflammatory bowel diseaseVirologyAntibodyInternal medicineOutbreakDiseaseInfectious disease (medical specialty)Inflammatory Bowel DiseaseSARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies